The synthetic lethality relationship between PTEN deficiency and mTOR-overexpression inhibition was discovered by showing an enhanced sensitivity of PTEN-deficient tumours to the mTOR inhibitor CCI-779, a rapamycin homologue (Neshat et al, 2001; Podsypanina et al, 2001). This evidence concerns the gene PTEN and neoplasm.